Skip to content

Clinical efficacy of coblation nucleoplasty for improving residual low back pain after percutaneous kyphoplasty: A single-center retrospective study

Clinical efficacy of coblation nucleoplasty for residual low back pain after percutaneous kyphoplasty

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600129412
Enrollment
Unknown
Registered
2026-08-04
Start date
2026-08-04
Completion date
Unknown
Last updated
2026-08-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Residual pain after percutaneous kyphoplasty

Interventions

receiving coblation nucleoplasty after percutaneous kyphoplasty:None
receiving conservative treatments including oral analgesics, rehabilitation exercises, and acupuncture after percutaneous vertebroplasty:None

Sponsors

NanJing First Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
55 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Patient age >= 55 years; 2. Imaging exams (X-ray, CT, and MRI) confirm a newly developed thoracolumbar vertebral compression fracture, with X-ray showing wedge-shaped vertebra, and MRI showing low signal on T1WI and high signal on T2WI; 3. Preoperative bone density test shows T-score less than -1.5 (using the left hip as reference); 4. Pre-PKP physical exam shows tenderness and percussion pain in the same vertebral segment as indicated by imaging; 5. No history of spinal surgery; 6. Patient has residual pain with VAS >= 4 after PKP at the fracture segment; 7. Meets CN surgical indications; 8. Patient has good compliance, comes for follow-ups on time, and follow-up data are complete.

Exclusion criteria

Exclusion criteria: 1.Presence of other factors that could contribute to residual pain, including soft-tissue injury in the lumbar and dorsal regions, spinal instability, recurrent fractures, fracture nonunion, and early-stage complications; 2.incomplete medical records, irregular follow-up visits, or failure to complete the planned follow-up; 3.Any other conditions that the investigators considered inappropriate for study enrollment;

Design outcomes

Primary

MeasureTime frame
Visual Analogue Scale (VAS);Japanese Orthopaedic Association Scores,JOA;

Countries

China

Contacts

Public ContactQiang Sun

NanJing First Hospital

sunqiang_cn@163.com+86 25 5227 1058

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Aug 25, 2026